Horizon Therapeutics PLC (NASDAQ:HZNP) released its quarterly earnings results on Wednesday, May, 6th. The biopharmaceutical company reported $0.40 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.21 by $0.19. For comparison, HZNP has a P/B of 4.62. Based on these metrics and many more, REGN holds a Value grade of B, while HZNP has a Value grade of C. REGN is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. View detailed financial information, real-time news, videos, quotes and analysis on Horizon Therapeutics Plc (NASDAQ:HZNP). Explore commentary on Horizon Therapeutics Plc and hear what the experts Horizon Therapeutics Plc To Release Fourth-Quarter And Full-Year 2019 Financial Results And Host Webcast On Feb. 26, 2020 By Business Wire Feb 4, 2020 8:00 AM EST Horizon Pharma, Inc. (NASDAQ: HZNP) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on
Horizon Therapeutics Public - Stock Price History | HZNP ...
HZNP Stock Quote of Horizon Therapeutics Check out our HZNP stock analysis, current HZNP quote, charts, and historical prices for Horizon Therapeutics stock. DOW / Nasdaq / S&P / About Us; Our Analysts; By Zacks Investment Research REGN vs. HZNP: Which Stock Is the Better Value Option?
Dec 20, 2019
Jan 23, 2020
Why Is Horizon Therapeutics (HZNP) Down 3.3% Since Last Earnings Report? Zacks Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.
60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. % of Institutional Shareholders: The percent of ownership held by large financial institutions or …
Should I buy Horizon Therapeutics Public Limited Company (HZNP)? Use the Zacks Rank and Style Scores View All Zacks #1 Ranked Stocks. Trades from $ 1.
HZNP -- Is Its Stock Price A Worthy Investment? Learn More. HZNP Stock Summary HZNP has a higher market value than 84.35% of US stocks; more precisely, its current market capitalization is $9,180,255,982. The price/operating cash flow metric for Horizon Therapeutics Public Ltd Co is higher than 87.43% of stocks in our set with a positive cash flow. HZNP Horizon Therapeutics Public Limited Company Stock Quote